PVB group (n = 38) | Control group (n = 38) | |
---|---|---|
Age (years) | 55 ± 11 | 56 ± 10 |
Male (n, %) | 22, 57.9% | 23, 60.5% |
BMI (kg•m−2) | 23.31 ± 3.15 | 23.60 ± 3.63 |
ASA I/II/III level | 19/18/1 | 15/22/1 |
Pain NRS | 0 (0,1) | 0 (0, 0) |
Neuropathy | 0, 0.0% | 0, 0.0% |
Severe sleep disorder | 0, 0.0% | 0, 0.0% |
Hemoglobin (g•L−1) | 139 ± 19 | 141 ± 19 |
Platelet (× 109•L−1) | 203 ± 87 | 179 ± 69 |
ALT (U•L−1) | 31 ± 24 | 31 ± 25 |
Albumin (g•L−1) | 42 ± 6 | 43 ± 4 |
Creatinine (μmol•L−1) | 72 ± 16 | 72 ± 14 |
PT (s) | 13 ± 1 | 12 ± 1 |
APTT (s) | 29 ± 4 | 28 ± 5 |